Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SMAR
2601
DELISTED
Smartsheet Inc.
SMAR
| $634K | ﹤0.01% |
20,175
+16,187
| +406% | +$671K |
|
2602
Repay Holdings
RPAY
$331M
| $630K | ﹤0.01% |
48,932
+5,679
| +13% | +$73.9K |
|
2603
Carter's
CRI
$1.47B
| $629K | ﹤0.01% |
8,929
+5,449
| +157% | +$439K |
|
2604
Dole
DOLE
$1.31B
| $629K | ﹤0.01% |
74,353
-392,471
| -84% | -$4.31M |
|
2605
Tango Therapeutics
TNGX
$4.69B
| $629K | ﹤0.01% |
138,836
+15,927
| +13% | +$96.4K |
|
2606
Paysafe
PSFE
$412M
| $628K | ﹤0.01% |
26,838
+18,713
| +230% | +$604K |
|
2607
CNA Financial
CNA
$14.2B
| $627K | ﹤0.01% |
13,951
+5,100
| +58% | +$234K |
|
2608
Freshpet
FRPT
$3.51B
| $627K | ﹤0.01% |
12,079
+3,891
| +48% | +$300K |
|
2609
Rush Enterprises Class B
RUSHB
$6.16B
| $627K | ﹤0.01% |
18,945
-1,099
| -5% | -$35.6K |
|
2610
Materion
MTRN
$6.18B
| $625K | ﹤0.01% |
8,478
-9,246
| -52% | -$743K |
|
|
RVNC
2611
DELISTED
Revance Therapeutics, Inc.
RVNC
| $625K | ﹤0.01% |
45,206
+24,790
| +121% | +$382K |
|
|
INVX
2612
Innovex International
INVX
$2.13B
| $624K | ﹤0.01% |
24,159
-23,815
| -50% | -$726K |
|
2613
Adeia
ADEA
$3.3B
| $623K | ﹤0.01% |
163,428
-194,205
| -54% | -$814K |
|
2614
Codere Online
CDRO
$404M
| $623K | ﹤0.01% |
221,526
+154,244
| +229% | +$577K |
|
2615
Ezcorp Inc
EZPW
$1.83B
| $622K | ﹤0.01% |
82,800
-35,500
| -30% | -$258K |
|
2616
FB Financial Corp
FBK
$3.09B
| $622K | ﹤0.01% |
15,861
-38,022
| -71% | -$1.53M |
|
|
AMK
2617
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $621K | ﹤0.01% |
33,098
+2,425
| +8% | +$48.5K |
|
|
SWAV
2618
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $621K | ﹤0.01% |
3,252
-5,170
| -61% | -$913K |
|
2619
Travere Therapeutics
TVTX
$5.84B
| $619K | ﹤0.01% |
25,556
-23,345
| -48% | -$587K |
|
2620
Karat Packaging
KRT
$845M
| $618K | ﹤0.01% |
36,223
-460
| -1% | -$8.62K |
|
2621
Myriad Genetics
MYGN
$301M
| $617K | ﹤0.01% |
33,953
-37,062
| -52% | -$770K |
|
|
ONL
2622
Orion Office REIT
ONL
$151M
| $617K | ﹤0.01% |
56,343
-13,366
| -19% | -$172K |
|
2623
Urban Outfitters
URBN
$6.67B
| $617K | ﹤0.01% |
33,101
-142,993
| -81% | -$3.24M |
|
2624
Donegal Group Class A
DGICA
$728M
| $616K | ﹤0.01% |
36,142
-1,712
| -5% | -$25.7K |
|
2625
Gray Television
GTN
$447M
| $616K | ﹤0.01% |
36,440
+18,519
| +103% | +$360K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 561 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 561 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.